Neuer Text
Neuer Text
Home
Welcome Message ICPO
Welcome Richard P. Baum
Invited Speakers
Scientfic Programme
Registration
Hotel Accomodation
Trade Exhibition
List of Sponsors
FAQs
Start Registration
Festschrift and Scrap Book
Neuer Text
Scientific Programme
Topics
History and perspectives of molecular targeted radiotherapy - old wine in new bottles
- From antibodies to antibodies –is there a future for radioimmunotherapy?
- The revolution started 25 years ago – SSTR agonists and antagonists
- Peptide radiochemistry – from Gallium-68 to Fluorine-18?
- New radioisotopes for theranostics – Terbium, Scandium and more
- Production of therapeutic radionuclides – will there be a bottle neck for Actinium?
- PSMA – a breakthrough in the diagnosis and treatment of prostate cancer
- FAPI – will it be the new FDG and the weapon for molecular radioligand therapy of all cancer types?
- Theranostics and Precision Cancer Medicine – from the shadows to storm the market
- Dosimetry: from retrospective to prospective?
- Artificial Intelligence, deep learning and Precision Oncology – a future without a caring physician?
- ICPO Academy for Precision Oncology (IAPO) - aims and challenges
- Total body PET/CT – will we be able to detect micrometastases in patients in less than 30 seconds?
- From patient to patient – how support groups can improve cancer treatment
Programme Guide Download
Share by: